Literature DB >> 9130144

Oligodendrocyte precursors survive poorly and do not migrate following transplantation into the normal adult central nervous system.

M T O'Leary1, W F Blakemore.   

Abstract

Cell cultures enriched for oligodendrocyte precursors were prepared for male neonatal rat pups and transplanted into the spinal cord white matter of normal and x-irradiated syngeneic adult female rats. Transplanted cells were detected using a probe specific for the rat Y chromosome immediately after transplantation and 14 days later. In non-x-irradiated tissue, significantly fewer cells were seen at 14 days compared with time zero, and no cell migration was observed. In x-irradiated tissue, cells both survived and migrated into the surrounding grey and white matter. The observed behaviour of oligodendrocyte precursors in normal adult tissue is in contrast to their behaviour in myelin mutants and neonates, where migration and survival have been well documented (Warrington et al., 1993; Lachapelle et al., 1994), but mimics the behaviour of the O-2A progenitor-like cell line, CG4, following transplantation into similar environments (Franklin et al., 1996). The findings in this study have profound implications for the use of grafts of oligodendrocyte precursors as a therapy in human demyelinating diseases, because they indicate that grafts will need to be introduced directly into each clinically relevant area of demyelination.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9130144

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  13 in total

1.  Transplantation of olfactory mucosa minimizes axonal branching and promotes the recovery of vibrissae motor performance after facial nerve repair in rats.

Authors:  Orlando Guntinas-Lichius; Konstantin Wewetzer; Toma L Tomov; Natalie Azzolin; Shohreh Kazemi; Michael Streppel; Wolfrum F Neiss; Doychin N Angelov
Journal:  J Neurosci       Date:  2002-08-15       Impact factor: 6.167

2.  Dual-modality monitoring of targeted intraarterial delivery of mesenchymal stem cells after transient ischemia.

Authors:  Piotr Walczak; Jian Zhang; Assaf A Gilad; Dorota A Kedziorek; Jesus Ruiz-Cabello; Randell G Young; Mark F Pittenger; Peter C M van Zijl; Judy Huang; Jeff W M Bulte
Journal:  Stroke       Date:  2008-03-06       Impact factor: 7.914

Review 3.  Cell therapy for multiple sclerosis.

Authors:  Tamir Ben-Hur
Journal:  Neurotherapeutics       Date:  2011-10       Impact factor: 7.620

Review 4.  Importance of oligodendrocyte protection, BBB breakdown and inflammation for remyelination.

Authors:  Jens Watzlawik; Arthur E Warrington; Moses Rodriguez
Journal:  Expert Rev Neurother       Date:  2010-03       Impact factor: 4.618

5.  Human monoclonal antibodies reactive to oligodendrocytes promote remyelination in a model of multiple sclerosis.

Authors:  A E Warrington; K Asakura; A J Bieber; B Ciric; V Van Keulen; S V Kaveri; R A Kyle; L R Pease; M Rodriguez
Journal:  Proc Natl Acad Sci U S A       Date:  2000-06-06       Impact factor: 11.205

6.  Oligodendrocytes engineered with migratory proteins as effective graft source for cell transplantation in multiple sclerosis.

Authors:  Ike de la Pena; Mibel Pabon; Sandra Acosta; Paul R Sanberg; Naoki Tajiri; Yuji Kaneko; Cesar V Borlongan
Journal:  Cell Med       Date:  2014-04-10

Review 7.  Unique in vivo properties of olfactory ensheathing cells that may contribute to neural repair and protection following spinal cord injury.

Authors:  Jeffery D Kocsis; Karen L Lankford; Masanori Sasaki; Christine Radtke
Journal:  Neurosci Lett       Date:  2009-01-17       Impact factor: 3.046

8.  Neuroprotective effects of oligodendrocyte progenitor cell transplantation in premature rat brain following hypoxic-ischemic injury.

Authors:  Long-Xia Chen; Si-Min Ma; Peng Zhang; Zi-Chuan Fan; Man Xiong; Guo-Qiang Cheng; Yi Yang; Zi-Long Qiu; Wen-Hao Zhou; Jin Li
Journal:  PLoS One       Date:  2015-03-19       Impact factor: 3.240

9.  Magnetic resonance imaging and cell-based neurorestorative therapy after brain injury.

Authors:  Quan Jiang
Journal:  Neural Regen Res       Date:  2016-01       Impact factor: 5.135

10.  Remyelination, axonal sparing, and locomotor recovery following transplantation of glial-committed progenitor cells into the MHV model of multiple sclerosis.

Authors:  Minodora O Totoiu; Gabriel I Nistor; Thomas E Lane; Hans S Keirstead
Journal:  Exp Neurol       Date:  2004-06       Impact factor: 5.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.